J. D. Kilburn et al.
7.0 Hz; ArH), 7.42–7.16 (m, 9H; ArH), 7.16 (brs, 1H; NH), 7.01 (brs,
1H; NH), 5.76 (brs, 1H; NH), 5.12 (s, 2H; CH2Ph), 4.45–4.30 (m, 2H),
4.19 (m, 2H; CH2), 3.60–3.15 (m, 8H; CH2CH2), 2.49 (m, 2H;
CH2COO), 2.13 (m, 1H), 2.01 (m, 1H), 1.40 ppm (s, 9H; (CH3)3C);
13C NMR (75 MHz, CDCl3): d=173.3 (C), 173.2 (C), 162.7 (C), 157.6
(C), 157.0 (C), 156.6 (C), 143.8 (C), 141.4 (C), 135.7 (C), 128.7 (CH),
128.4 (CH), 128.3 (CH), 127.9 (CH), 127.2 (CH), 125.3 (CH), 120.1
(CH), 116.7 (C), 80.6 (C), 67.3 (CH2), 66.8 (CH2), 54.8 (CH), 47.1 (CH2),
41.9 (CH2), 41.0 (CH2), 39.6 (CH2), 38.9 (CH2), 30.4 (CH2), 28.4 ppm
(CH3); IR (neat): n˜ =1629 (m), 1522 (m), 1449 (m), 1242 (m), 1166 (m),
1140 (m), 848 (w), 739 (m), 514 cmꢀ1 (s); LRMS (ES): m/z: 783 [M+H]+,
805 [M+Na]+.
the resin with K2CO3 (0.15m) in MeOH/DMF/water (2:2:1, 23 h). Final-
ly, the resin was washed as above, rinsed with diethyl ether, and dried in
vacuo.
Acknowledgements
We wish to thank EPSRC for supporting this work (GRLꢀ98916/01) and
the BBSRC for a studentship (JS).
4-{2-[N’-(2-tert-Butoxycarbonylaminoethyl)-N’’-(2,2,2-trifluoroacetyl)gua-
nidino]ethylcarbamoyl}-4-(9H-fluoren-9-ylmethoxycarbonylamino)buty-
ric acid (21): Palladium on charcoal (10% by wt, 10 mol%, 8 mg) was
added to a solution of ester 20 (55 mg, 70 mmol) in EtOH (5 mL). The
mixture was stirred under a hydrogen atmosphere for 2 h and then fil-
tered through Celite. Finally, the solvent was removed by evaporation
under reduced pressure to give 21 as an off-white hygroscopic foam
(43 mg, 88%). 1H NMR (300 MHz, CDCl3): d=9.47 (brs, 1H; NH), 7.74
(d, 2H, J=7.5 Hz; ArH), 7.55 (d, 2H, J=6.5 Hz; ArH), 7.44 (brs, 1H;
NH), 7.42–7.22 (m, 4H; ArH), 6.18 (brs, 1H; NH), 5.88 (brs, 1H; NH),
4.45–4.38 (m, 3H), 4.17 (m, 1H; CH), 3.70–2.95 (m, 8H; CH2CH2), 2.44
(m, 2H; CH2COO), 2.18–1.82 (m, 2H), 1.40 ppm (s, 9H; (CH3)3C);
13C NMR (75 MHz, CDCl3): d=180.1 (C), 176.2 (C), 173.7 (C), 171.7
(C), 159.9 (C), 157.8 (C), 156.7 (C), 143.7 (C), 141.4 (C), 127.9 (CH),
127.3 (CH), 125.3 (CH), 120.1 (CH), 80.7 (C), 67.5 (CH2), 55.7 (CH),
54.6 (CH), 47.1 (CH2), 41.9 (CH2), 41.1 (CH2), 39.6 (CH2), 38.7 (CH2),
30.0 (CH2), 28.4 ppm (CH3); IR (neat): n˜ =2977 (br, w), 1628 (s), 1524
(m), 1449 (m), 1243 (m), 1139 (s), 909 (m), 844 (m), 734 cmꢀ1 (s); LRMS
(ES): m/z: 693 [M+H]+, 715 [M+Na]+.
Resin-bound receptor 23: TentaGelSNH2 resin (0.2 mmolgꢀ1, 162.2 mg,
32.4 mmol) was swollen in CH2Cl2 and drained. A solution of acid 21
(34 mg, 48.7 mmol), DIC (15 ml, 97.3 mmol), HOBt (13 mg, 97.3 mmol),
and DIPEA (17 ml, 97.3 mmol) in DMF (2 mL) was then added to the
resin, and the mixture agitated on a tube rotator for 18 h. Any remaining
amine residues were capped by treating the resin with an excess of acetic
anhydride. The resin was then filtered and washed with CH2Cl2 (3
5 mL), DMF (35 mL), and additional CH2Cl2 (35 mL). A ninhydrin
test was negative. There then followed three sequential cycles of cou-
pling/Fmoc deprotection to add Fmoc-Gly, Fmoc-Val, and Fmoc-Val to
the resin, and to synthesize the first arm of the receptor. This was a-
chieved by using Fmoc-protected amino acid (97 mmol), DIC (12 mg,
97 mmol), HOBt (13 mg, 97 mmol), and DIPEA (17 ml, 97 mmol) in DMF
(2 mL). Ninhydrin tests were used to monitor progress of each coupling
reaction and the coupling reactions were repeated until complete. After
deprotection of the second Val residue, the chain was capped by the
treatment of the resin with acetic anhydride (9 ml, 97.3 mmol) and
DIPEA (17 ml, 97.3 mmol) in DMF (2 mL). Boc deprotection (see general
procedure) was followed by three sequential coupling/deprotection cycles
to add Fmoc-Met, Fmoc-His(Trt), and Fmoc-Ser(OtBu) to the resin also
by using the Fmoc-protected amino acid (97 mmol), DIC (12 mg,
97 mmol), HOBt (13 mg, 97 mmol), and DIPEA (17 ml, 97 mmol) in DMF
(2 mL); this time to synthesize the second arm of the receptor. Ninhydrin
tests were used to monitor the progress of each coupling reaction. Trt de-
protection was achieved by the treatment of the resin with 95% TFA/
CH2Cl2 (21 h), followed by washing with CH2Cl2 (35 mL), 50%
DIPEA/DMF (35 mL), DMF (35 mL), and additional CH2Cl2 (3
5 mL). Trifluoroacetyl deprotection was carried out by the treatment of
[1] For a recent review on peptide receptors see: a) M. W. Peczuh,
A. D. Hamilton, Chem. Rev. 2000, 100, 2479–2493.
[2] a) C. Chamorro, R. M. J. Liskamp, Tetrahedron 2004, 60, 11145–
11157; b) C. Chamorro, J.-W. Hofman, R. M. J. Liskamp, Tetrahe-
dron 2004, 60, 8691–8699; c) C. Schmuck, M. Heil, Org. Biomol.
Chem. 2003, 1, 633–636; d) C. Schmuck, M. Heil, ChemBioChem
2003, 4, 1232–1238; e) K. B. Jensen, T. M. Braxmeier, M. Demarcus,
J. D. Kilburn, Chem. Eur. J. 2002, 8, 1300–1309.
[3] a) H. Wennemers, M. C. Nold, M. Conza, K. J. Kulicke, M. Neubur-
ger, Chem. Eur. J. 2003, 9, 442–448; b) H. Wennemers, M. Conza, J.
Org. Chem. 2002, 67, 2696–2698; c) R. Arienzo, J. D. Kilburn, Tetra-
hedron 2002, 58, 711–719; d) T. Braxmeier, M. Demarcus, T. Fes-
smann, S. McAteer, J. D. Kilburn, Chem. Eur. J. 2001, 7, 1889–1898;
e) J. D. Kilburn, T. Fessmann, Angew. Chem. 1999, 111, 2170–2174;
Angew. Chem. Int. Ed. 1999, 38, 1993–1996.
[4] Other recent examples of sequence selective peptide receptors:
a) C. Schmuck, L. Geiger, J. Am. Chem. Soc. 2004, 126, 8898–8899;
b) S. Rensing, T. Schrader, Org. Lett. 2002, 4, 2161–2164; c) R. Xu,
G. Greiveldinger, L. E. Marenus, A. Cooper, J. A. Ellman, J. Am.
Chem. Soc. 1999, 121, 4898–4899; d) M. Sirish, H.-J. Schneider, J.
Chem. Soc. Chem. Commun. 1999, 907–908; e) Md. A. Hossain, H.-
J. Schneider, J. Am. Chem. Soc. 1998, 120, 11208–11209; f) R. Bre-
slow, Z. Yang, R. Ching, G. Trojandt, F. Odobel, J. Am. Chem. Soc.
1998, 120, 3536–3537.
[5] a) N. Srinivasan, J. D. Kilburn, Curr. Opin. Chem. Biol. 2004, 8, 305–
310; b) B. Linton, A. D. Hamilton, Curr. Opin. Chem. Biol. 1999, 3,
307–312.
[6] C. Schmuck, P. Frey, M. Heil, ChemBioChem 2005, 6, 628–631.
[7] a) D. H. Williams, Nat. Prod. Rep. 1996, 13, 469–477; b) M. L.
Cohen, Science 1992, 257, 1050–1055; c) H. C. Neu, Science 1992,
257, 1064–1073.
[8] S. Bartoli, K. B. Jensen, J. D. Kilburn, J. Org. Chem. 2003, 68, 9416–
9422.
[9] S. R. Chhabra, B. Hothi, D. J. Evans, P. D. Wite, B. W. Bycroft, W. C.
Chan, Tetrahedron Lett. 1998, 39, 1603–1606.
[10] P. Edman, G. Begg, Eur. J. Biochem. 1967, 1, 80–91; sequencing was
performed by using an applied biosystems 477 A pulsed liquid-phase
sequencer, coupled online to an applied biosystems 120 A phenyl-
thiohydantoin (PTH) derivative analyzer.
[11] H. Rink, Tetrahedron Lett. 1987, 28, 3787–3790.
[12] a) M. Conza, H. Wennemers, Chem. Commun. 2003, 866–867;
b) M. C. F. Monnee, A. J. Brouwer, L. M. Verbeek, A. M. A. van -
Wageningen, R. M. J. Liskamp, Bioorg. Med. Chem. Lett. 2001, 11,
1521–1525; c) Y. Cheng, T. Suenaga, W. C. Still, J. Am. Chem. Soc.
1996, 118, 1813–1814.
Received: July 25, 2005
Published online: October 14, 2005
720
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2006, 12, 713 – 720